Visiting CPHI Barcelona?
Schedule a Meet

Atorvastatin EP Impurity A

Product Information

Product Atorvastatin EP Impurity A
CAT No. CS-O-07285
CAS No. 433289-83-9
Status Available for Dispatch by 24-Sep-2023
Category Impurities
Mol. Wt. 559.68 mol/g
Mol. For. C₃₃H₃₅Ca₀.₅N₂O₅
Hazardous Hazard

Product Description

Atorvastatin EP Impurity A is a chemical compound that is commonly used as a reference standard in the pharmaceutical industry. This impurity is often used in the development and testing of drugs that are used to treat a variety of cardiovascular conditions such as high cholesterol and heart disease. The chemical formula for Atorvastatin EP Impurity A is C26H40O8, and it has a molecular weight of 480.59 g/mol. This impurity is a white to off-white powder that is soluble in most organic solvents. It is also stable under normal conditions of use and storage. In terms of its usage, Atorvastatin EP Impurity A is often used in the development of analytical methods for the detection and quantification of atorvastatin and its related compounds. It is also used as a reference standard in quality control and manufacturing processes to ensure the purity and potency of atorvastatin-based drugs. Overall, Atorvastatin EP Impurity A is an important chemical compound in the pharmaceutical industry, and its use is critical for the development and production of safe and effective drugs for the treatment of cardiovascular disease.

Additional Information

Packing Product will be supplied in Vials, in certain conditions we also use 'Septa Vials'
Controlled No
Parent API Atorvastatin
Purity Not less than 90%
Therapeutic Anti-Diabetic
Smileys CC(C)C1=C(C(=C(N1CCC(CC(CC(=O)[O-])O)O)C2=CC=CC=C2)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4.CC(C)C1=C(C(=C(N1CCC(CC(CC(=O)[O-])O)O)C2=CC=CC=C2)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4.[Ca+2]
Canonical Smiles CC(C)C1=C(C(=C(N1CCC(CC(CC(=O)[O-])O)O)C2=CC=CC=C2)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4.CC(C)C1=C(C(=C(N1CCC(CC(CC(=O)[O-])O)O)C2=CC=CC=C2)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4.[Ca+2]
Inchl InChI=1S/2C33H36N2O5.Ca/c2*1-22(2)31-30(33(40)34-25-16-10-5-11-17-25)29(23-12-6-3-7-13-23)32(24-14-8-4-9-15-24)35(31)19-18-26(36)20-27(37)21-28(38)39;/h2*3-17,22,26-27,36-37H,18-21H2,1-2H3,(H,34,40)(H,38,39);/q;;+2/p-2/t2*26-,27-;/m11./s1
IUPAC calcium;(3R,5R)-7-[2,3-diphenyl-4-(phenylcarbamoyl)-5-propan-2-ylpyrrol-1-yl]-3,5-dihydroxyheptanoate
Hazardous Yes

Need a Quote?

Your email address will not be published. Required fields are marked *

Safety & Handling Information

General Information Use proper personal protective equipment
Handling Wash thoroughly after handling. Remove contaminated clothing and wash before reuse. Avoid contact with eyes, skin, and clothing. Avoid ingestion and inhalation.
Engineering Control Use adequate general or local exhaust ventilation to keep airborne concentrations below the permissible exposure limits. Use process enclosure, local exhaust ventilation, or other engineering controls to control airborne levels.
Clothing Wear appropriate protective clothing to minimize contact with skin.
Skin Wear appropriate protective gloves and clothing to prevent skin exposure.
Eyes Wear safety glasses and chemical goggles if splashing is possible.
Inhalation Remove from exposure and move to fresh air immediately.

What we promise?

  • 30-Days Money Back
  • Complete Documentation
  • Worldwide Delivery
  • Product Accuracy

Sample Label

logo Atorvastatin EP Impu... www.clearsynth.com 
 CAT : CS-O-07285 BATCH : CSC-WWW0757

 MF: C₃₃H₃₅Ca₀.₅N₂O₅
 CAS: 433289-83-9
 Date of Anaysis: 19-Aug-2023
 Retest Date: 19-Jun-2026
MW: 559.68

Store at refrigerator (2-8C)
Qty: 60 MG 
 Only for R & D and Analytical purpose, Not for Human Consumption.

Sample Packaging

Sample Packaging

Sample Vials

Sample Vials
Product List

Related Products